Applied Biopharm Consulting is pleased to announce the opening of its new business address at the West Cork Business and Technology Park in Clonakilty, marking a significant milestone in the company’s continued growth.
Founded by Dr Anthony Newcombe, an industry veteran with a strong track record at companies such as GSK and Pfizer, Applied Biopharm Consulting offers specialised support in GMP auditing, manufacturing science and technology (MSAT), regulatory CMC strategy, technical transfer and quality assurance.
The firm works closely with pharmaceutical and biotech companies developing innovative therapies, with particular expertise in advanced biologics and next-generation gene therapies.
During the past 2 years, Applied Biopharm has rapidly expanded its client base, forging partnerships with leading firms across the EU, US and Asia-Pacific.
The company’s ability to provide tailored, science-driven support has been a key driver of its growing reputation as a trusted advisor in the life sciences sector.
In 2024, the company secured a feasibility study grant from the Local Enterprise Office Cork North & West.
This funding enabled Applied Biopharm to evaluate the commercial and technical viability of a cutting-edge capsid-engineering technology designed to enhance gene therapy delivery.
The research leveraged AI-based protein modelling, highlighting the company's ongoing focus on integrating digital tools with biologic innovation.
“This step reflects our continued growth and commitment to working with biotech innovators worldwide,” said Dr Newcombe.
“Having a presence at the West Cork Business and Technology Park also puts us in a strong position to scale our activities in consulting, gene therapy, and bioprocess development. We’re excited to expand our footprint while staying close to the scientific and entrepreneurial ecosystem in Cork.”
The West Cork Business and Technology Park is a premier destination for tech-driven and service-oriented businesses, offering excellent infrastructure, reliable connectivity and proximity to major transport links.
The park currently hosts more than 1000 professionals and supports a collaborative environment ideal for companies with global reach.
As Applied Biopharm enters this new chapter, the company plans to deepen its investment in innovation, talent development, and strategic collaborations.
Its new base in Clonakilty not only enhances operational capabilities but also reinforces the firm’s long-term vision of becoming a leading consulting partner in the global biotechnology industry.